Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001493152-21-029137)

Filing Details

Accession Number:: 0001493152-21-029137
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-11-17 17:05:37
Reporting Period:: 2021-10-28

Accepted Time:: 2021-11-17 17:05:37
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1349929	Vyant Bio Inc.	VYNT	Services-Medical Laboratories (8071)	043462475

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1894066	Jr. Thomas Robert Fremeau	C/O Vyant Bio, Inc. 2 Executive Campus 2370 State Route 70, Suite 310 Cherry Hill, NJ 08002	Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.0001 Par Value	Acquisiton	2021-10-28	1,000	$2.19	1,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock option (right to buy)	Acquisiton	2021-11-01	250,000	$0.00	250,000	$2.55

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
250,000		2031-11-01	No	4	A	Direct

Footnotes

The option shall become exercisable with respect to twenty five percent (25%) of the shares underlying the option on November 1, 2022, and the remaining seventy five percent (75%) of the shares underlying the option shall vest in thirty six (36) equal monthly installments commencing December 1, 2022; provided that the participant remains a service provider to the Company through each applicable vesting date